Reducing Inpatient Length of Stay Using a Multicollaborative Protocol for Management of Non-Intensive Care Unit Asthmatics

Mandeep S Jassal, Christy Sadreameli, Iona Pereira, Stacey Mann, Catherine Garger, Carlton K Lee, Lauren McAvoy, Marybeth Vidunas, Nancy Stanley, Judith Rohde

Research output: Contribution to journalArticle

Abstract

Maximizing clinical efficiency through the reduction in inpatient length of stay (LOS) using standardized protocols has been a major objective among hospital administrators, most notably in the context of recent healthcare reimbursement changes at statewide levels. The objective of our project was to determine whether a synchronous change in an inpatient asthma protocol that relied on a respiratory therapist (RT)-driven bronchodilator weaning algorithm and bronchodilator therapy given through a metered dose inhaler (MDI) plus valved holding chamber (VHC) could impact clinical and financial outcomes. A pre-post study assessed patients aged 2-21 years of age admitted with a primary diagnosis of status asthmaticus. The effect of the protocol was measured from October 2014 to July 2015. Outcome variables included patient demographics, hospital LOS, all-patient refined diagnosis-related groups (APR-DRGs), and inpatient charges. Outcomes were compared between the preimplementation and postimplementation time periods. Statistical significance was measured using Wilcoxon signed-rank test and bootstrap logistic regression models. Protocol patients (n = 110) had a similar demographic and clinical profile compared with the matched population from the previous nonprotocol fiscal year (n = 150). Use of the protocol resulted in a significantly reduced LOS that maintained significance after adjusting for APR-DRGs weight (P < 0.05). The protocol did not alter the total hospital billing charges. A nonstatistically significant reduction in 30-day readmission rates was observed among those administered the protocol. An RT-led weaning protocol using a quantitative scoring system and MDI+VHC for bronchodilator administration resulted in a significantly reduced LOS.

Original languageEnglish (US)
Pages (from-to)118-124
Number of pages7
JournalPediatric, Allergy, Immunology, and Pulmonology
Volume29
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Inpatients
Length of Stay
Inhalation Spacers
Bronchodilator Agents
Metered Dose Inhalers
Diagnosis-Related Groups
Weaning
Logistic Models
Demography
Status Asthmaticus
Hospital Administrators
Hospital Charges
Nonparametric Statistics
Asthma
Delivery of Health Care
Weights and Measures
Population
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Reducing Inpatient Length of Stay Using a Multicollaborative Protocol for Management of Non-Intensive Care Unit Asthmatics. / Jassal, Mandeep S; Sadreameli, Christy; Pereira, Iona; Mann, Stacey; Garger, Catherine; Lee, Carlton K; McAvoy, Lauren; Vidunas, Marybeth; Stanley, Nancy; Rohde, Judith.

In: Pediatric, Allergy, Immunology, and Pulmonology, Vol. 29, No. 3, 01.09.2016, p. 118-124.

Research output: Contribution to journalArticle

Jassal, Mandeep S ; Sadreameli, Christy ; Pereira, Iona ; Mann, Stacey ; Garger, Catherine ; Lee, Carlton K ; McAvoy, Lauren ; Vidunas, Marybeth ; Stanley, Nancy ; Rohde, Judith. / Reducing Inpatient Length of Stay Using a Multicollaborative Protocol for Management of Non-Intensive Care Unit Asthmatics. In: Pediatric, Allergy, Immunology, and Pulmonology. 2016 ; Vol. 29, No. 3. pp. 118-124.
@article{c423e0b3eb3b41ad804bd8819309ac6e,
title = "Reducing Inpatient Length of Stay Using a Multicollaborative Protocol for Management of Non-Intensive Care Unit Asthmatics",
abstract = "Maximizing clinical efficiency through the reduction in inpatient length of stay (LOS) using standardized protocols has been a major objective among hospital administrators, most notably in the context of recent healthcare reimbursement changes at statewide levels. The objective of our project was to determine whether a synchronous change in an inpatient asthma protocol that relied on a respiratory therapist (RT)-driven bronchodilator weaning algorithm and bronchodilator therapy given through a metered dose inhaler (MDI) plus valved holding chamber (VHC) could impact clinical and financial outcomes. A pre-post study assessed patients aged 2-21 years of age admitted with a primary diagnosis of status asthmaticus. The effect of the protocol was measured from October 2014 to July 2015. Outcome variables included patient demographics, hospital LOS, all-patient refined diagnosis-related groups (APR-DRGs), and inpatient charges. Outcomes were compared between the preimplementation and postimplementation time periods. Statistical significance was measured using Wilcoxon signed-rank test and bootstrap logistic regression models. Protocol patients (n = 110) had a similar demographic and clinical profile compared with the matched population from the previous nonprotocol fiscal year (n = 150). Use of the protocol resulted in a significantly reduced LOS that maintained significance after adjusting for APR-DRGs weight (P < 0.05). The protocol did not alter the total hospital billing charges. A nonstatistically significant reduction in 30-day readmission rates was observed among those administered the protocol. An RT-led weaning protocol using a quantitative scoring system and MDI+VHC for bronchodilator administration resulted in a significantly reduced LOS.",
author = "Jassal, {Mandeep S} and Christy Sadreameli and Iona Pereira and Stacey Mann and Catherine Garger and Lee, {Carlton K} and Lauren McAvoy and Marybeth Vidunas and Nancy Stanley and Judith Rohde",
year = "2016",
month = "9",
day = "1",
doi = "10.1089/ped.2016.0673",
language = "English (US)",
volume = "29",
pages = "118--124",
journal = "Pediatric, Allergy, Immunology, and Pulmonology",
issn = "2151-321X",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Reducing Inpatient Length of Stay Using a Multicollaborative Protocol for Management of Non-Intensive Care Unit Asthmatics

AU - Jassal, Mandeep S

AU - Sadreameli, Christy

AU - Pereira, Iona

AU - Mann, Stacey

AU - Garger, Catherine

AU - Lee, Carlton K

AU - McAvoy, Lauren

AU - Vidunas, Marybeth

AU - Stanley, Nancy

AU - Rohde, Judith

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Maximizing clinical efficiency through the reduction in inpatient length of stay (LOS) using standardized protocols has been a major objective among hospital administrators, most notably in the context of recent healthcare reimbursement changes at statewide levels. The objective of our project was to determine whether a synchronous change in an inpatient asthma protocol that relied on a respiratory therapist (RT)-driven bronchodilator weaning algorithm and bronchodilator therapy given through a metered dose inhaler (MDI) plus valved holding chamber (VHC) could impact clinical and financial outcomes. A pre-post study assessed patients aged 2-21 years of age admitted with a primary diagnosis of status asthmaticus. The effect of the protocol was measured from October 2014 to July 2015. Outcome variables included patient demographics, hospital LOS, all-patient refined diagnosis-related groups (APR-DRGs), and inpatient charges. Outcomes were compared between the preimplementation and postimplementation time periods. Statistical significance was measured using Wilcoxon signed-rank test and bootstrap logistic regression models. Protocol patients (n = 110) had a similar demographic and clinical profile compared with the matched population from the previous nonprotocol fiscal year (n = 150). Use of the protocol resulted in a significantly reduced LOS that maintained significance after adjusting for APR-DRGs weight (P < 0.05). The protocol did not alter the total hospital billing charges. A nonstatistically significant reduction in 30-day readmission rates was observed among those administered the protocol. An RT-led weaning protocol using a quantitative scoring system and MDI+VHC for bronchodilator administration resulted in a significantly reduced LOS.

AB - Maximizing clinical efficiency through the reduction in inpatient length of stay (LOS) using standardized protocols has been a major objective among hospital administrators, most notably in the context of recent healthcare reimbursement changes at statewide levels. The objective of our project was to determine whether a synchronous change in an inpatient asthma protocol that relied on a respiratory therapist (RT)-driven bronchodilator weaning algorithm and bronchodilator therapy given through a metered dose inhaler (MDI) plus valved holding chamber (VHC) could impact clinical and financial outcomes. A pre-post study assessed patients aged 2-21 years of age admitted with a primary diagnosis of status asthmaticus. The effect of the protocol was measured from October 2014 to July 2015. Outcome variables included patient demographics, hospital LOS, all-patient refined diagnosis-related groups (APR-DRGs), and inpatient charges. Outcomes were compared between the preimplementation and postimplementation time periods. Statistical significance was measured using Wilcoxon signed-rank test and bootstrap logistic regression models. Protocol patients (n = 110) had a similar demographic and clinical profile compared with the matched population from the previous nonprotocol fiscal year (n = 150). Use of the protocol resulted in a significantly reduced LOS that maintained significance after adjusting for APR-DRGs weight (P < 0.05). The protocol did not alter the total hospital billing charges. A nonstatistically significant reduction in 30-day readmission rates was observed among those administered the protocol. An RT-led weaning protocol using a quantitative scoring system and MDI+VHC for bronchodilator administration resulted in a significantly reduced LOS.

UR - http://www.scopus.com/inward/record.url?scp=84987851772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987851772&partnerID=8YFLogxK

U2 - 10.1089/ped.2016.0673

DO - 10.1089/ped.2016.0673

M3 - Article

AN - SCOPUS:84987851772

VL - 29

SP - 118

EP - 124

JO - Pediatric, Allergy, Immunology, and Pulmonology

JF - Pediatric, Allergy, Immunology, and Pulmonology

SN - 2151-321X

IS - 3

ER -